ISPOR 2019

ISPOR 2019 Convened Nearly 4000 HEOR Healthcare Stakeholders

ISPOR, the professional society for health economics and outcomes research (HEOR), recently concluded its ISPOR 2019 annual conference in New Orleans, LA, USA. The conference convened nearly 4000 healthcare stakeholders representing more than 65 countries and from all sectors of healthcare, including policy makers, global thought leaders, researchers and academicians, public and private payers, healthcare providers, and patient engagement organizations. The conference centered on the timely theme, “Rapid. Disruptive. Innovative. A New Era in HEOR,” and addressed a wide variety of compelling topics in HEOR.

Speakers

All Speakers

Daniel Kraft, MD

Faculty Chair for Medicine, Singularity University, | Founder and Chair, Exponential Medicine, Stanford, CA, USA

Alexander Billioux, M.D, D.Phil.,

Assistant Secretary | Office of Public Health, Louisiana Department of Health, Baton Rouge, LA

Clifford Goodman, PhD

Senior Vice President | The Lewin Group, Falls Church, VA, USA

Colleen M. Flood, F.R.S.C.

Director | University of Ottawa Centre for Health Law, Policy and Ethics, Ottawa, ON, Canada

Timothy Caulfield, LLM, FRSC, FCAHS

Canada Research Chair, Professor, and Research Director | University of Alberta, Edmonton, AB, Canada

Fleur Chandler

Health Economist and Project HERCULES Chair | Patient Advisory Board, Duchenne UK, London, UK

Ron Philip

Chief Commercial Officer | Spark Therapeutics, Inc., Philadelphia, PA, USA

Laurie Burke, MPH

Founder LORA Group, LLC and Affiliate Associate Professor, | University of Maryland School of Pharmacy, Department of Pharmaceutical Health Services Research, Royal Oak, MD, USA

Harindra Wijeysundera, MD, PhD

Vice-President | Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa, ON, Canada

Kevin Marsh, PhD

Executive Director | Patient-Centered Research, Evidera Ltd, Newport Pagell, UK

Martin Ho, MS

Associate Director for Quantitative Innovation | Center for Devices and Radiological Health (CDRH), U.S. Food and Drug Administration, Silver Springs, MD, USA

Juan Marcos Gonzalez Sepulveda, PhD

Assistant Professor | Population Health Sciences, Preference Evaluation Research Group, Duke University, Durham, NC, USA

Sebastian Heidenreich, PhD

Senior Research Associate | Patient Preferences, Evidera, Aberdeen, UK

William Crown, PhD

Chief Scientific Officer | Optum Labs, Cambridge, USA

Pall Jónsson, PhD

Associate Director, Research and Development | National Institute for Health and Care Excellence, London, United Kingdom

Kurt D. Christensen, PhD

Instructor in Medicine | Brigham and Women’s Hospital, Boston, USA

Hidde Hovenkamp, MSc

Director | Pacmed, Amsterdam, The Netherlands

C. Daniel Mullins, PhD

Professor, Pharmaceutical Health Services Research | University of Maryland, School of Pharmacy, Baltimore, MD, USA

Joel Hay, PhD

Professor of Pharmaceutical and Health Economics | USC School of Pharmacy, Los Angeles, CA, USA

Josephine A. Mauskopf, PhD, MHA, MA

Vice President, Health Economics | RTI Health Solutions, Durham, NC, USA

Mike Drummond, PhD

Professor of Health Economics, Centre for Health Economics | University of York, Heslington, York, England, UK

Mark Trusheim, MS, BS

Strategic Director | NEWDIGS and Visiting Scientist MIT, Boston, MA

Muna Bhanji, RPh

Senior Vice President, Global Market Access | Merck

Stephen A. Hull, MHS

Principal & Founder | Hull Associates LLC, Rockland, MA, USA

Paul Coplan, ScD, MBA, FISPE

Vice President & Head of Epidemiology and Real World Data Sciences, Medical Devices and Office of Chief Medical Officer | Johnson and Johnson, New Brunswick, NJ, USA